EODData

FRA, 5HZ1: HANGZHOU TIGERMED CO. H 1

21 Nov 2025
LAST:

3.980

CHANGE:
 0.22
OPEN:
4.020
HIGH:
4.020
ASK:
0.000
VOLUME:
883
CHG(%):
5.24
PREV:
4.200
LOW:
3.960
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 254.0204.0203.9603.980883
20 Nov 254.2004.2004.2004.200883
19 Nov 254.3404.3404.2804.280883
18 Nov 254.4804.4804.4204.420883
17 Nov 254.5004.5004.4604.460883
14 Nov 254.8204.8204.7804.780883
13 Nov 254.9404.9404.8804.900883
12 Nov 254.9004.9004.8404.840883
11 Nov 254.8604.8604.7804.780883
10 Nov 255.0505.0504.9804.980883

PROFILE

Name:HANGZHOU TIGERMED CO. H 1
About:Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Sector:Healthcare
Address:Shengda Science Park, Building A, Hangzhou, China, 310051
Website:https://www.tigermedgrp.com
ISIN:CNE1000040M1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:57.22 
Forward P/E:12.77 
Price to Sales:0.90 
Price to Book:0.21 
Profit Margin:0.09 
Operating Margin:0.11 
Return on Assets:0.01 
Return on Equity:0.03 
DivYield:0.06 
Div/Share:0.30 
Revenue:799.18M 
EBITDA:129.44M 
Shares:123.13M 
Market Cap:490.04M 

TECHNICAL INDICATORS

MA5:4.277.2%
MA10:4.5614.6%
MA20:4.7118.4%
MA50:4.8221.1%
MA100:5.0927.9%
MA200:4.349.2%
RSI14:22.55 
WPR14:-100.00 
MTM14:-0.96
ROC14:-0.19 
ATR:0.17 
Week High:4.8221.1%
Week Low:3.960.5%
Month High:5.1529.4%
Month Low:3.969.2%
Year High:6.4461.7%
Year Low:2.7644.4%
Volatility:2.39 

RECENT DIVIDENDS

Date Amount
12 Jun 2025$0.04
07 Jun 2024$0.07
29 May 2024$0.62
25 May 2023$0.07
24 May 2022$0.06